Real-World Efficacy of Atezolizumab in Patients with Previously Treated Advanced NSCLC in Spain - TRACKER Study

被引：0
|
作者：
Alvarez, R. [1 ]
Carcereny, E. [2 ,3 ]
Padilla, A. [4 ]
Rodriguez Garcia, J. M. [5 ]
Cordoba, J. F. [6 ]
Esteban, E. [7 ]
Aguado, C. [8 ]
Garde, J. [9 ]
Moreno Vega, A. [10 ]
Avila Andrade, C. [11 ]
Sereno, M. [12 ]
Sanchez-Hernandez, A. [13 ]
Lopez-Brea, M. [14 ]
Massuti, B. [15 ]
Marti Blanco, C. [16 ]
Campayo, M. [17 ]
Arnaiz, P. [18 ]
Perez Parente, D. [18 ]
Fajardo, C. A. [18 ]
Ramos, I. [19 ]
机构：
[1] Hosp Gregorio Maranon, Madrid, Spain
[2] Catalan Inst Oncol ICO Badalona, Germans Trias & Pujol Res Inst IGTP, Dept Med Oncol, Badalona, Spain
[3] Badalona Appl Res Grp Oncol B ARGO, Germans Trias & Pujol Res Inst IGTP, Badalona, Spain
[4] Hosp Univ Nuestra Senora Candelaria, Santa Cruz De Tenerife, Spain
[5] Hosp San Pedro Alcantara, Caceres, Spain
[6] Hosp Arnau Vilanova, Lleida, Spain
[7] Hosp Univ Cent Asturias, Oviedo, Spain
[8] Hosp Clin San Carlos, Madrid, Spain
[9] Hosp Arnau Vilanova, Valencia, Spain
[10] Hosp Univ Reina Sofia, Cordoba, Spain
[11] Hosp Lluis Alcanyis Xativa, Valencia, Spain
[12] Hosp Infanta Sofia, Madrid, Spain
[13] Consorci Hosp Prov Castello, Castellon De La Plana, Spain
[14] Hosp Univ Marques Valdecilla, Santander, Spain
[15] Hosp Gen Alicante, Alicante, Spain
[16] Hosp Univ Sant Joan Reus, Reus, Spain
[17] Hosp Univ Mutua Terrassa, Terrassa, Spain
[18] Roche Farma SA, Madrid, Spain
[19] Hosp Univ Virgen Victoria, Malaga, Spain
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
Real-World Data; NSCLC; atezolizumab;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP11.03-13
引用
收藏
页码：S625 / S626
页数：2
相关论文
共 50 条
  • [31] Plasma ddPCR for the detection of MET amplification in advanced NSCLC patients: a comparative real-world study
    Su, Jun-Wei
    Weng, Cheng-Di
    Lin, Xiao-Cheng
    Fang, Mei-Mei
    Xiao, Xiao
    Zhang, Yi-Chen
    Zhang, Xu-Chao
    Su, Jian
    Xu, Chong-Rui
    Yan, Hong-Hong
    Chen, Hua-Jun
    Wu, Yi-Long
    Yang, Jin-Ji
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2024, 16
  • [32] Impact of Smoking on Survival in NSCLC Patients Treated with Chemoimmunoimmunotherapy or Chemotherapy: A Real-world Data Study
    Mostafa, A. A. Bani
    Al-Akhras, A.
    Tashtoush, S.
    Hamouri, S.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S420 - S421
  • [33] Cabozantinib Plus Atezolizumab in First or Second-Line Advanced NSCLC and Previously-Treated EGFR Mutant Advanced NSCLC
    Neal, J. W.
    Lim, F. L.
    Aix, S. P.
    Viteri, S.
    Santoro, A.
    Spencer, K.
    Fang, B.
    Khrizman, P.
    Kim, J.
    Subbiah, V.
    Sudhagoni, R.
    Samaraweera, L.
    Andrianova, L.
    Felip, E.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S439 - S439
  • [34] Real-world efficacy of nivolumab in Peruvian patients with advanced melanoma
    Roque, Katia
    Valencia, Guillermo
    Rioja, Patricia
    Huaman Campos, Jose Andres
    Colomo Costas, Valeria
    Mantilla, Raul
    Morante, Zaida
    Fuentes, Hugo
    Munante, Bruno
    Vidaurre, Tatiana
    Neciosup, Silvia P.
    De Mello, Ramon Andrade B.
    Leonidas Gomez, Henry
    Castaneda Altamirano, Carlos Arturo
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [35] Thyroid Disfunction in Advanced NSCLC Patients Treated with Nivolumab out of Clinical Trial: A Real-World Data Analysis
    Palmero, R.
    Ruffinelli, J. C.
    Alanya, E.
    Marin, J. A.
    Ferrer, M.
    Jove, M.
    Mesia, C.
    Arellano, M.
    Brao, I.
    Cardenal, F.
    Peiro, I.
    Nadal, E.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2432 - S2432
  • [36] Real-world long-term outcomes of advanced/metastatic NSCLC patients treated with EGFR TKIs in Nottinghamshire
    Lopez-Escola, C.
    Mengoli, K.
    Sheikh, O.
    Karim, S.
    Sadiq, M.
    LUNG CANCER, 2020, 139 : S62 - S62
  • [37] Real-World treatment outcomes for advanced NSCLC in Greece
    Kokkotou, Eleni
    Stournara, Lamprini
    Mani, Maria
    Gkiozos, Ioannis
    Tsagouli, Sofia
    Syrigos, Nikolaos
    Burke, Thomas
    Desiniotis, Andreas
    Dimitriadis, Ioannis
    Charpidou, Andriani
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [38] Impact of Afatinib Dosing on Safety and Efficacy Real-World in Patients with EGFR Mutation-Positive Advanced NSCLC
    Halmos, B.
    Tan, E.
    Soo, R.
    Cadranel, J.
    Lee, M. K.
    Foucher, P.
    Hsia, T.
    Hochmair, M.
    Griesinger, F.
    Hida, T.
    Kim, E.
    Melosky, B.
    Maerten, A.
    Carcereny, E.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S470 - S471
  • [39] Real-world data of zanubrutinib treatment for patients with previously treated Waldenstrom Macroglobulinemia
    Jang, Seo Yoon
    Kwon, Soyean
    Byun, Ja Min
    Koh, Youngil
    Hong, Junshik
    Yoon, Sung-Soo
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S277 - S277
  • [40] Real-world evaluation of racial and socioeconomic disparities in patients with NSCLC treated with immunotherapy
    Rivers, Zachary
    Nimeiri, Halla
    Hyun, Seung Won
    Charlot, Marjorie
    Fuchs, Joseph
    Dressler, Danielle
    Ben-Shachar, Rotem
    Patel, Jyoti
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (07) : E15 - E15
12345